retatrutide clinical trial status New Phase 3 data just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats TRIUMPH-3 🇦🇺 retatrutide cardiovascular/obesity clinical

Glucagon receptor activation ramps up thermogenesis and fat oxidation, meaning your body burns more energy even at rest

This article is for educational and informational purposes only and does not constitute medical advice

Weight loss from GLP-1s can also reduce or eliminate arthritis, joint pain, or hypertension

SeekPeptides members get access to detailed protocol guides, updated research summaries, and expert-curated resources that go far beyond what a single article can cover

With compounded GLP-1 therapy, your physician must guide you in determining the correct dosage

The manufacturer of retatrutide, Lilly, has issued warnings to the public about the dangers of buying counterfeit medication